参考文献/References:
[1] Grewal IS,Flavell RA.A centeal role of CD40 ligand in the regulation of CD4+ T-cell responses[J].Immunol Today,1996,17(9):410-414.
[2] Bond MG,Barnes RW,Riley WA,et al.High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study(ARIC).The ARIC Study Group[J].J Neuroimaging,1991,1(2):68-73.
[3] Bak S,Gaist D,Sindrup SH,et al.Genetic liability in stroke:a long-term follow-up study of Danish twins[J].Stroke,2002,33(3):769-774.
[4] Sayed-Tabatabaei FA,Schut AF,Hofman A,et al.A study of gene-environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach[J].J Med Genet,2004,41(2):99-103.
[5] Ilveskoski E,Loimaala A,Mercuri MF,et al.Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men[J].Atherosclerosis,2000,153(1):147-153.
[6] Leus FR,Wittekoek ME,Prins J,et al.Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia[J].Atherosclerosis,2000,149(2):371-377.
[7] Lindi VI,Uusitupa MI,Lindstr m J,et al.Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the finnish diabetes prevention study[J].Diabetes,2002,51(8):2581-2586.
[8] Rundek T,Elkind MS,Pittman J,et al.Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes-The Northern Manhattan Prospective Cohort Study[J].Stroke,2002,33(5):1420-1423.
[9] Klupa T,Malecki MT,Pezzolesi M,et al.Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2[J].Diabetes,2000,49(12):2212-2216.
[10] 王瑞连,朱梅佳.胰岛素受体基因多态性与动脉粥样硬化的研究进展[J].中国动脉粥样硬化杂志,2006,14(10):911-913.
[11] Araki E,Lipes MA,Patti ME,et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene[J]. Nature,1994,372(652):186-190.
[12] He W,Craparo A,Zhu Y,et al.Interaction of insulin receptor substrate-2(IRS-2)with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2[J].J Biol Chem,1996,271(20):11641-11645.
[13] Stefan N,Fritsche A,Machicao F,et al.The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function[J].Diabetologia,2004,47(4):761-762.
[14] Mazzoccoli G,Dagostino MP,Fontana A,et al.Influence of the Gly1057Asp variant of the insulin receptor substrate 2(IRS2)on insulin resistance and relationship with epicardial fat thickness in the elderly[J].Exp Gerontol,2012,47(12):988-993.
[15] Villuendas G,Botella-Carretero JI,Sancho JA,et al.Polymorphisms in the insulin receptor substrate-1(IRS-1)gene and the insulin receptor substrate-2(IRS-2)gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls[J].Human Reproduction,2005,20(11):3184-3191.
[16] Ruan Y,Ma J,Xie X. Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis[J].Endocr J,2012, 59(7):601-609.
[17] Lin MW,Huang MF,Wu MH,et al.Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population[J].J Ovarian Res,2014,7(7):92-99.
[18] Chan SH,Chen JH,Li YH,et al.Gly1057Asp polymorphism of insulin receptor substrate-2 is associated with coronary artery disease in the Taiwanese population[J].J Biomed Sci,2012,19(19):100-108.